Cefaclor: Anaphylaxis: case report.
In: Reactions Weekly, Jg. 1926 (2022-10-01), Heft 1, S. 158-158
serialPeriodical
Zugriff:
Further, the patient developed cardiac arrest, due to which the patient died. Allergy, Asthma and Clinical Immunology 17: 20, 2021. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important event In a retrospective study involving 459 patients, who reported adverse drug reactions to cefaclor at pharmacovigilance centers at two tertiary hospitals between January 2014 and December 2018, a patient [ I age and sex not stated i ] was described, who developed anaphylaxis following antibiotic therapy with cefaclor [ I route, dosage and duration of treatment to reaction onset not stated i ]. [Extracted from the article]
Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Cefaclor: Anaphylaxis: case report.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 1926 (2022-10-01), Heft 1, S. 158-158 |
Veröffentlichung: | 2022 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-022-24436-z |
Schlagwort: |
|
Sonstiges: |
|